PNR
72
10
EMC
70
12
FLS
55
3
ALL
51
7
HAL
50
-4
PEG
51
-2
IR
83
3
D
33
-4
MSFT
60
5
PYPL
52
5
RRC
76
-2
HIG
70
-6
DRI
48
-12
BRK.B
47
-3
KMI
46
-2
COP
51
-2
DTE
40
-2
ROK
46
3
APH
73
2
TXT
66
3
PNR
72
10
EMC
70
12
FLS
55
3
ALL
51
7
HAL
50
-4
PEG
51
-2
IR
83
3
D
33
-4
MSFT
60
5
PYPL
52
5
RRC
76
-2
HIG
70
-6
DRI
48
-12
BRK.B
47
-3
KMI
46
-2
COP
51
-2
DTE
40
-2
ROK
46
3
APH
73
2
TXT
66
3
Financhill
Back

GlycoMimetics Quote, Financials, Valuation and Earnings

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.
Sell
17

GLYC
GlycoMimetics

Last Price:
1.65
Seasonality Move:
17.46%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.

GlycoMimetics Price Quote

$1.65
+0.01 (+-3.51%)
(Updated: April 27, 2024 at 6:06 AM ET)

GlycoMimetics Key Stats

Sell
17
GlycoMimetics (GLYC) is a Sell
Day range:
$1.63 - $1.76
52-week range:
$1.11 - $3.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.75%
Volume:
964.6K
Avg. volume:
640.4K
1-year change:
19.71%
Market cap:
$105.7M
Revenue:
$10K
EPS:
$-0.58

How Much Does GlycoMimetics Make?

Data Unavailable

Is GlycoMimetics Growing As A Company?

Data Unavailable

GlycoMimetics Stock Price Performance

  • Did GlycoMimetics Stock Go Up Last Month?
    GlycoMimetics share price went down by -42.46% last month
  • Did GLYC's Share Price Rise Over The Last Year?
    GLYC share price rose by 19.71% over the past 1 year

What Is GlycoMimetics 52-Week High & Low?

GlycoMimetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy GlycoMimetics?

  • How Much Debt Does GlycoMimetics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does GlycoMimetics Have?
    Cash and short term investments quarterly total is $41.8M
  • What Is GlycoMimetics’s Book Value Per Share?
    Book value per share is 0.60

Is GlycoMimetics Cash Flow Positive?

  • What Is GLYC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34.9M
  • What Is GlycoMimetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $28.8M
  • What Is GlycoMimetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$21.4K

GlycoMimetics Return On Invested Capital

  • Is Management Doing A Good Job?
    GLYC return on invested capital is -75.34%
  • What Is GlycoMimetics Return On Assets?
    ROA measures how assets are converting to revenues and is -65.64%
  • What Is GLYC Return On Equity?
    ROE is a measure of profitability and is -75.34%

GlycoMimetics Earnings Date & Stock Price

GlycoMimetics Competitors

  • Who Are GlycoMimetics's Competitors?
    Below is a list of companies who compete with GlycoMimetics or are related in some way:
    • Altimmune Inc (ALT)
    • Cellectar Biosciences Inc (CLRB)
    • Precision BioSciences Inc (DTIL)
    • PDS Biotechnology Corp (PDSB)
    • Syros Pharmaceuticals Inc (SYRS)

GlycoMimetics Dividend Yield

Data Unavailable

GlycoMimetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.69%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 326.83%

Major Shareholders

  • How many GLYC shares are owned by institutional investors?
    53.3M GLYC shares are owned by institutional investors
  • How many GLYC shares are owned by insiders?
    2.2M GLYC shares are owned by insiders